Genmab buys ADC technology license from Synaffix
![Photo: Tuala Hjarnø / Genmab / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13611108.ece/ALTERNATES/schema-16_9/doc7j4vvsoxwed18y1x7eeb.jpg)
A new licensing agreement will secure Genmab the right to use technologies developed by Dutch biotech company Synaffix.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Janssen applies for FDA approval for Genmab drug
For subscribers